{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T21:15:49Z","timestamp":1778015749919,"version":"3.51.4"},"reference-count":45,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background and Aim<\/jats:title>\n                    <jats:p>Machine learning based on clinical data and treatment protocols for better clinical decision-making is a current research hotspot. This study aimed to build a machine learning model on washed microbiota transplantation (WMT) for ulcerative colitis (UC), providing patients and clinicians with a new evaluation system to optimize clinical decision-making.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Methods<\/jats:bold>\n                    <\/jats:p>\n                    <jats:p>Patients with UC who underwent WMT via mid-gut or colonic delivery route at an affiliated hospital of Nanjing Medical University from April 2013 to June 2022 were recruited. Model ensembles based on the clinical indicators were constructed by machine-learning to predict the clinical response of WMT after one month.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Results<\/jats:bold>\n                    <\/jats:p>\n                    <jats:p>\n                      A total of 366 patients were enrolled in this study, with 210 patients allocated for training and internal validation, and 156 patients for external validation. The low level of indirect bilirubin, activated antithrombin III, defecation frequency and cholinesterase and the elderly and high level of creatine kinase, HCO\n                      <jats:sub>3<\/jats:sub>\n                      <jats:sup>-<\/jats:sup>\n                      and thrombin time were related to the clinical response of WMT at one month. Besides, the voting ensembles exhibited an area under curve (AUC) of 0.769\u00a0\u00b1\u00a00.019 [accuracy, 0.754; F1-score, 0.845] in the internal validation; the AUC of the external validation was 0.614\u00a0\u00b1\u00a00.017 [accuracy, 0.801; F1-score, 0.887]. Additionally, the model was available at\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/wmtpredict.streamlit.app\">https:\/\/wmtpredict.streamlit.app<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Conclusions<\/jats:bold>\n                    <\/jats:p>\n                    <jats:p>This study pioneered the development of a machine learning model to predict the one-month clinical response of WMT on UC. The findings demonstrate the potential value of machine learning applications in the field of WMT, opening new avenues for personalized treatment strategies in gastrointestinal disorders.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Trial registration<\/jats:bold>\n                    <\/jats:p>\n                    <jats:p>\n                      clinical trials, NCT01790061. Registered 09 February 2013 - Retrospectively registered,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT01790061\">https:\/\/clinicaltrials.gov\/study\/NCT01790061<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1016\/j.csbj.2024.08.021","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T07:28:01Z","timestamp":1724484481000},"page":"583-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A predictive machine-learning model for clinical decision-making in washed microbiota transplantation on ulcerative colitis"],"prefix":"10.34133","volume":"24","author":[{"given":"Sheng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaochen","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenchen","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medicine & Therapeutics, the Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bota","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Microbiota Medicine & Medical Center for Digestive Diseases, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"Jiangsu Engineering Research Center for Advanced Microbiota Medicine, Key Lab of Holistic Integrative Enterology, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, China"},{"name":"National Clinical Research Center for Digestive Diseases, Xi'an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.mayocp.2014.07.002","article-title":"Ulcerative colitis: epidemiology, diagnosis, and management [J","volume":"89","author":"Feuerstein J.D.","year":"2014","unstructured":"Feuerstein J.D. and Cheifetz A.S.: Ulcerative colitis: epidemiology, diagnosis, and management [J. Mayo Clin Proc 2014; 89: 1553.","journal-title":"Mayo Clin Proc"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32126-2"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-318131"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304833"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.4"},{"key":"e_1_3_6_7_2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/1751-2980.13227","article-title":"Washed microbiota transplantation for Clostridioides difficile infection: a national multicenter real-world study","volume":"24","author":"Wu X.","year":"2023","unstructured":"Wu X., Ai R.J., Xu J. et al: Washed microbiota transplantation for Clostridioides difficile infection: a national multicenter real-world study. J Dig Dis 2023; 24: 540.","journal-title":"J Dig Dis"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002339"},{"key":"e_1_3_6_9_2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13238-019-00684-8","article-title":"Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening","volume":"11","author":"ZHANG T.","year":"2020","unstructured":"ZHANG T., LU G., ZHAO Z. et al: Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell 2020; 11: 251.","journal-title":"Protein Cell"},{"key":"e_1_3_6_10_2","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1097\/CM9.0000000000000954","article-title":"Nanjing consensus on methodology of washed microbiota transplantation","volume":"133","author":"FECAL MICROBIOTA TRANSPLANTATION-STANDARDIZATION STUDY GROUP","year":"2020","unstructured":"FECAL MICROBIOTA TRANSPLANTATION-STANDARDIZATION STUDY GROUP: Nanjing consensus on methodology of washed microbiota transplantation. Chin Med J (Engl) 2020; 133: 2330.","journal-title":"Chin Med J (Engl)"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.14074"},{"key":"e_1_3_6_12_2","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1136\/gutjnl-2022-327811","article-title":"Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial","volume":"71","author":"Kedia S.","year":"2022","unstructured":"Kedia S., Virmani S., Sk V. et al: Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial. Gut 2022; 71: 2401.","journal-title":"Gut"},{"key":"e_1_3_6_13_2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello S.P.","year":"2019","unstructured":"Costello S.P., Hughes P.A., Waters O. et al: Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. Jama 2019; 321: 156.","journal-title":"Jama"},{"key":"e_1_3_6_14_2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/1751-2980.12938","article-title":"Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis","volume":"21","author":"Chen M.","year":"2020","unstructured":"Chen M., Liu X.L., Zhang Y.J. et al: Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis. J Dig Dis 2020; 21: 621.","journal-title":"J Dig Dis"},{"key":"e_1_3_6_15_2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40264-019-00809-2","article-title":"Long-term safety and efficacy of fecal microbiota transplant in active ulcerative colitis","volume":"42","author":"Ding X.","year":"2019","unstructured":"Ding X., Li Q., Li P. et al: Long-term safety and efficacy of fecal microbiota transplant in active ulcerative colitis. Drug Saf 2019; 42: 869.","journal-title":"Drug Saf"},{"key":"e_1_3_6_16_2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.5009\/gnl210369","article-title":"Exploration of potential gut microbiota-derived biomarkers to predict the success of fecal microbiota transplantation in ulcerative colitis: a prospective cohort in Korea","volume":"16","author":"Kang G.U.","year":"2022","unstructured":"Kang G.U., Park S., Jung Y. et al: Exploration of potential gut microbiota-derived biomarkers to predict the success of fecal microbiota transplantation in ulcerative colitis: a prospective cohort in Korea. Gut liver 2022; 16: 775.","journal-title":"Gut liver"},{"key":"e_1_3_6_17_2","first-page":"1","article-title":"Older patients benefit more from sequential courses of washed microbiota transplantation than younger population with ulcerative colitis","author":"Liu Y.","year":"2023","unstructured":"Liu Y., Ji X., Huang Y. et al: Older patients benefit more from sequential courses of washed microbiota transplantation than younger population with ulcerative colitis. Scand J Gastroenterol 2023; : 1.","journal-title":"Scand J Gastroenterol"},{"key":"e_1_3_6_18_2","first-page":"2349","article-title":"Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery","volume":"15","author":"Lu G.","year":"2022","unstructured":"Lu G., Wang W., Li P. et al: Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery. Micro Biotechnol 2022; 15: 2349.","journal-title":"Micro Biotechnol"},{"key":"e_1_3_6_19_2","article-title":"Colonic transendoscopic enteral tubing is a new pathway to microbial therapy, colonic drainage, and host-microbiota interaction research","volume":"12","author":"Wang W.","year":"2023","unstructured":"Wang W., Lu G., Wu X. et al: Colonic transendoscopic enteral tubing is a new pathway to microbial therapy, colonic drainage, and host-microbiota interaction research. J Clin Med 2023; 12.","journal-title":"J Clin Med"},{"key":"e_1_3_6_20_2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2468-1253(22)00022-X","article-title":"AJM300 (carotegrast methyl), an oral antagonist of \u03b14-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"7","author":"Matsuoka K.","year":"2022","unstructured":"Matsuoka K., Watanabe M., Ohmori T. et al: AJM300 (carotegrast methyl), an oral antagonist of \u03b14-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. Lancet Gastroenterol Hepatol 2022; 7: 648.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"e_1_3_6_21_2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2013.09.060","article-title":"Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies","volume":"12","author":"Kelly C.R.","year":"2014","unstructured":"Kelly C.R., Kunde S.S. and Khoruts A.: Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies. Clin Gastroenterol Hepatol 2014; 12: 283.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_3_6_22_2","first-page":"2825","article-title":"Scikit-learn: machine learning in python","volume":"12","author":"Pedregosa F.","year":"2011","unstructured":"Pedregosa F., Varoquaux G., Gramfort A. et al: Scikit-learn: machine learning in python. J Mach Learn Res 2011; 12: 2825.","journal-title":"J Mach Learn Res"},{"key":"e_1_3_6_23_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jamiaopen\/ooy012","article-title":"tableone: an open source Python package for producing summary statistics for research papers","volume":"1","author":"Pollard T.J.","year":"2018","unstructured":"Pollard T.J., Johnson A.E.W., Raffa J.D. et al: tableone: an open source Python package for producing summary statistics for research papers. JAMIA Open 2018; 1: 26.","journal-title":"JAMIA Open"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.148.3.6878708"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-015-0068-x"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2009.11.009"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-018-0304-0"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.001"},{"key":"e_1_3_6_29_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104088","article-title":"Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis","volume":"81","author":"Rees N.P.","year":"2022","unstructured":"Rees N.P., Shaheen W., Quince C. et al: Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis. EBioMedicine 2022; 81: 104088.","journal-title":"EBioMedicine"},{"key":"e_1_3_6_30_2","article-title":"The underlying changes in serum metabolic profiles and efficacy prediction in patients with extensive ulcerative colitis undergoing fecal microbiota transplantation","volume":"15","author":"Wu X.","year":"2023","unstructured":"Wu X., Li P., Wang W. et al: The underlying changes in serum metabolic profiles and efficacy prediction in patients with extensive ulcerative colitis undergoing fecal microbiota transplantation. Nutrients 2023; 15.","journal-title":"Nutrients"},{"key":"e_1_3_6_31_2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1053\/j.gastro.2015.07.003","article-title":"Biomarkers of inflammation in inflammatory bowel disease","volume":"149","author":"Sands B.E.","year":"2015","unstructured":"Sands B.E.: Biomarkers of inflammation in inflammatory bowel disease. Gastroenterology 2015; 149: 1275. e2.","journal-title":"Gastroenterology"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0646-2"},{"key":"e_1_3_6_33_2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cgh.2022.07.027","article-title":"Prognostic value of fecal calprotectin to inform treat-to-target monitoring in ulcerative colitis","volume":"21","author":"Dulai P.S.","year":"2023","unstructured":"Dulai P.S., Feagan B.G., Sands B.E. et al: Prognostic value of fecal calprotectin to inform treat-to-target monitoring in ulcerative colitis. Clin Gastroenterol Hepatol 2023; 21: 456. e7.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_3_6_34_2","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1007\/s10620-022-07506-8","article-title":"Artificial intelligence for inflammatory bowel diseases (IBD); accurately predicting adverse outcomes using machine learning","volume":"67","author":"Zand A.","year":"2022","unstructured":"Zand A., Stokes Z., Sharma A. et al: Artificial intelligence for inflammatory bowel diseases (IBD); accurately predicting adverse outcomes using machine learning. Dig Dis Sci 2022; 67: 4874.","journal-title":"Dig Dis Sci"},{"key":"e_1_3_6_35_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158227","article-title":"Short-term surveillance of cytokines and c-reactive protein cannot predict efficacy of fecal microbiota transplantation for ulcerative colitis","volume":"11","author":"Zhang T.","year":"2016","unstructured":"Zhang T., Cui B., Li P. et al: Short-term surveillance of cytokines and c-reactive protein cannot predict efficacy of fecal microbiota transplantation for ulcerative colitis. PLoS One 2016; 11: e0158227.","journal-title":"PLoS One"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317263"},{"key":"e_1_3_6_37_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10620-019-05838-6","article-title":"Acetylcholinesterase inhibitor pyridostigmine bromide attenuates gut pathology and bacterial dysbiosis in a murine model of ulcerative colitis","volume":"65","author":"Singh S.P.","year":"2020","unstructured":"Singh S.P., Chand H.S., Banerjee S. et al: Acetylcholinesterase inhibitor pyridostigmine bromide attenuates gut pathology and bacterial dysbiosis in a murine model of ulcerative colitis. Dig Dis Sci 2020; 65: 141.","journal-title":"Dig Dis Sci"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.46.0237"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001466"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179267"},{"key":"e_1_3_6_41_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00384-020-03774-w","article-title":"Association between serum bilirubin and mucosal healing among Japanese patients with ulcerative colitis: a cross-sectional study","volume":"36","author":"Shiraishi K.","year":"2021","unstructured":"Shiraishi K., Furukawa S., Yagi S. et al: Association between serum bilirubin and mucosal healing among Japanese patients with ulcerative colitis: a cross-sectional study. Int J Colorectal Dis 2021; 36: 377.","journal-title":"Int J Colorectal Dis"},{"key":"e_1_3_6_42_2","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14281","article-title":"The association between bilirubin concentrations and inflammatory bowel disease: insights from a systematic review and meta-analysis","author":"Zoroddu S.","year":"2024","unstructured":"Zoroddu S., Di Lorenzo B., Paliogiannis P. et al: The association between bilirubin concentrations and inflammatory bowel disease: insights from a systematic review and meta-analysis. Eur J Clin Invest 2024; : e14281.","journal-title":"Eur J Clin Invest"},{"key":"e_1_3_6_43_2","first-page":"228","article-title":"Efficacy of serum total bilirubin in predicting the severity of ulcerative colitis: a cross-sectional study","volume":"50","author":"Zhang M.H.","year":"2020","unstructured":"Zhang M.H., Wang H.G., Shi Y.T. et al: Efficacy of serum total bilirubin in predicting the severity of ulcerative colitis: a cross-sectional study. Ann Clin Lab Sci 2020; 50: 228.","journal-title":"Ann Clin Lab Sci"},{"key":"e_1_3_6_44_2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7150\/thno.87739","article-title":"Targeted modulation of intestinal epithelial regeneration and immune response in ulcerative colitis using dual-targeting bilirubin nanoparticles","volume":"14","author":"Zhuo Z.","year":"2024","unstructured":"Zhuo Z., Guo K., Luo Y. et al: Targeted modulation of intestinal epithelial regeneration and immune response in ulcerative colitis using dual-targeting bilirubin nanoparticles. Theranostics 2024; 14: 528.","journal-title":"Theranostics"},{"key":"e_1_3_6_45_2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/jgh.16435","article-title":"Fecal microbiota transplantation through transendoscopic enteral tubing for inflammatory bowel disease: high acceptance and high satisfaction","volume":"39","author":"Lin J.","year":"2024","unstructured":"Lin J., Xiong J., Jin Y. et al: Fecal microbiota transplantation through transendoscopic enteral tubing for inflammatory bowel disease: high acceptance and high satisfaction. J Gastroenterol Hepatol 2024; 39: 328.","journal-title":"J Gastroenterol Hepatol"},{"key":"e_1_3_6_46_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/CM9.0000000000003020","article-title":"Concept, breakthrough, and future of colonic transendoscopic enteral tubing","volume":"137","author":"Zhang F.","year":"2024","unstructured":"Zhang F., Lu G., Wang X. et al: Concept, breakthrough, and future of colonic transendoscopic enteral tubing. Chin Med J (Engl) 2024; 137: 633.","journal-title":"Chin Med J (Engl)"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037024002800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037024002800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2024.08.021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:56:37Z","timestamp":1778014597000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2024.08.021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":45,"alternative-id":["10.1016\/j.csbj.2024.08.021"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2024.08.021","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A predictive machine-learning model for clinical decision-making in washed microbiota transplantation on ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2024.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}